| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/01/2002 | US20020102540 Functional dna clone for hepatitis c virus (hcv) and uses thereof |
| 08/01/2002 | US20020102537 Retroviral production |
| 08/01/2002 | US20020102535 Nucleic acid molecules and polypeptides for immune modulation |
| 08/01/2002 | US20020102534 Exhaustive analysis of viral protein interactions by two-hybrid screens and selection of correctly folded viral interacting polypeptides |
| 08/01/2002 | US20020102329 Alpha-galactosidases from Thermotoga maritima are used to hydrolyze indigestible oligosaccharides commonly found in animal feeds and for the removal of galactose-containing oligosaccharides in the making of edible soybean protein |
| 08/01/2002 | US20020102327 Novel bread improving composition |
| 08/01/2002 | US20020102276 For diagnosis, therapy and prophylaxis of Neisseria meningitidis infection; vaccine |
| 08/01/2002 | US20020102273 Vaccines to protect animals from disease, particularly from disease caused by protozoan parasites such as Toxoplasma gondii, helminth parasites, ectoparasites, fungi, bacteria, or viruses |
| 08/01/2002 | US20020102270 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 08/01/2002 | US20020102265 For diagnosis and imaging of cancer and tumor tissues |
| 08/01/2002 | US20020102263 Diagnosis and treatment of malignant neoplasms |
| 08/01/2002 | US20020102254 For diagnostic and therapeutic uses in cancer |
| 08/01/2002 | US20020102252 Novel isoforms of human pregnancy-associated protein-E |
| 08/01/2002 | US20020102247 For therapy of hyperproliferative disorders |
| 08/01/2002 | US20020102245 14-3-3sigma arrests the cell cycle |
| 08/01/2002 | US20020102244 Obtaining a cell sample which contains a stem cell; detecting the expression of BCRP by a cell in the cell sample; wherein a cell that expresses BCRP is identified as a stem cell |
| 08/01/2002 | US20020102242 Compositions and methods for administering pneumococcal DNA |
| 08/01/2002 | US20020102234 Contacting pure or recombinant mammalian (interleukin)IL- 1 delta or IL-L1 epsilon with a receptor comprising the IL-1R6 receptor subunit; or mammalian IL-1 delta or IL-1 epsilon with a receptor to form complex |
| 08/01/2002 | US20020102210 Treating target organism having a developing gonadal cell responsive to protein with potential modulator(s) of cell migration; observing change in migration or shape of developing gonadal cell attributable to presence of modulator |
| 08/01/2002 | US20020102091 Glass capillary array for fluorescence analysis and manufacturing method thereof |
| 08/01/2002 | DE10103695A1 Verwendung von Sialyltransferasen für die Diagnose und Therapie von Tumorerkrankungen Sialyltransferases of use in the diagnosis and therapy of tumor diseases |
| 08/01/2002 | DE10103694A1 Verwendung von EST-Sequenzen oder Varianten der Unigene-Cluster HS1, HS2 und/oder HS3 für die Diagnose und Therapie von Tumorerkrankungen sowie therapeutische Mittel Use of EST sequences or variants of Unigene Cluster HS1, HS2 and / or HS3 for the diagnosis and therapy of tumor diseases as well as therapeutic agents |
| 08/01/2002 | DE10102977A1 Testsystem zur Entwicklung von Therapeutika, insbesondere von Wirkstoffen zur Behandlung von Osteoporose Test system for the development of therapeutics, in particular of drugs used to treat osteoporosis |
| 08/01/2002 | DE10102389A1 Verfahren und Vektoren zur Plastidentransformation höherer Pflanzen Methods and vectors for plastid transformation of higher plants |
| 08/01/2002 | DE10101962A1 DNA-Sequenz mit regulatorischen Bereichen zur Expression von Proteinen DNA sequence with regulatory regions for expression of proteins |
| 08/01/2002 | DE10101793A1 Verwendung von SLPI zur Behandlung chronisch-entzündlicher Darmerkrankungen Use of SLPI in the treatment of chronic inflammatory bowel disease |
| 08/01/2002 | DE10101761A1 Verfahren zur Herstellung von homogenen Nukleinsäure-Multimeren für pharmazeutische Zusammensetzungen A process for the preparation of homogeneous nucleic acid multimer of Pharmaceutical Compositions |
| 08/01/2002 | DE10101501A1 Verfahren zur fermentativen Herstellung von Pantothensäure A process for the fermentative production of pantothenic acid |
| 08/01/2002 | DE10100493A1 Nachweis von pathogenen Bakterien Detection of pathogenic bacteria |
| 08/01/2002 | DE10063879A1 Nucleinsäuren, die vacuoläre Invertasen codieren, Pflanzenzellen und Pflanzen, die diese enthalten sowie ihre Verwendung Nucleic acids encoding the vacuolar invertase, plant cells and plants containing them and their use |
| 08/01/2002 | CA2792244A1 A method for identification, isolation and production of antigens to a specific pathogen |
| 08/01/2002 | CA2473308A1 Assay and kit for analyzing gene expression |
| 08/01/2002 | CA2467657A1 Process for determining target function and identifying drug leads |
| 08/01/2002 | CA2440703A1 Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer |
| 08/01/2002 | CA2436091A1 Neutralizing human monoclonal antibodies against hiv-1, their production and uses |
| 08/01/2002 | CA2435949A1 Biological organism for preparing pharmaceutical compositions for treating mammals |
| 08/01/2002 | CA2435910A1 Oomycete ftsz-mt as a target for antimicrobial-specific biocides |
| 08/01/2002 | CA2435826A1 Differentiation of stem cells to pancreatic endocrine cells |
| 08/01/2002 | CA2435776A1 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 08/01/2002 | CA2435672A1 Polypeptides capable of binding to cd64 and comprising one or more heterologous t cell epitopes, and their uses |
| 08/01/2002 | CA2435631A1 Methods and compositions for expressing polynucleotides specifically in smooth muscle cells in vivo |
| 08/01/2002 | CA2435622A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 08/01/2002 | CA2435612A1 Polynucleotides for use as tags and tag complements, manufacture and use thereof |
| 08/01/2002 | CA2435610A1 Cytoplasmic gene inhibition or gene expression in transfected plants by a tobraviral vector |
| 08/01/2002 | CA2435510A1 Methods for screening for substances which inhibit fp prostanoid receptor interaction with a compound having pgf2.alpha.alphaactivity and methods of treating cancer |
| 08/01/2002 | CA2435433A1 High level cytokine production with enhanced cell viability |
| 08/01/2002 | CA2435047A1 Constitutively desensitized g protein-coupled receptors |
| 08/01/2002 | CA2434897A1 Human lipase and polynucleotides encoding the same |
| 08/01/2002 | CA2434896A1 Novel human kinases and polynucleotides encoding the same |
| 08/01/2002 | CA2434847A1 Cytoplasmic inhibition of gene expression and expression of a foreign protein in a monocot plant by a plant viral vector |
| 08/01/2002 | CA2434845A1 Hepatitis c virus replicons and replicon enhanced cells |
| 08/01/2002 | CA2434602A1 Novel inositol polyphosphate kinase genes and uses thereof |
| 08/01/2002 | CA2434320A1 Chemokines as adjuvants of immune response |
| 08/01/2002 | CA2434139A1 Nucleic-acid programmable protein arrays |
| 08/01/2002 | CA2433869A1 Gene for identifying individuals with familial dysautonomia |
| 08/01/2002 | CA2433867A1 Retroviral vectors for transduction into quiescent cells and packaging systems for them |
| 08/01/2002 | CA2433834A1 Activatable cytolytic or drug delivery peptides and uses thereof |
| 08/01/2002 | CA2433681A1 Sulfatases and methods of use thereof |
| 08/01/2002 | CA2433680A1 Double-stranded rna-mediated gene suppression |
| 08/01/2002 | CA2433227A1 Specific human antibodies for selective cancer therapy |
| 08/01/2002 | CA2432991A1 Genes overexpressed in prostate disorders as diagnostic and therapeutic targets |
| 08/01/2002 | CA2432276A1 Regulation of cell growth by muc1 |
| 08/01/2002 | CA2432134A1 Adenylate cyclases |
| 08/01/2002 | CA2431517A1 Polynucleotides encoding cellular transporters and methods of use thereof |
| 08/01/2002 | CA2431493A1 Aminoacyl trna synthetases |
| 08/01/2002 | CA2431313A1 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators |
| 08/01/2002 | CA2431177A1 Trem-1 splice variant for use in modifying immune responses |
| 08/01/2002 | CA2431144A1 Cell adhesion proteins |
| 08/01/2002 | CA2430762A1 Colon cancer marker |
| 08/01/2002 | CA2430743A1 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 08/01/2002 | CA2429779A1 Adipocyte complement related protein zacrp13 |
| 08/01/2002 | CA2429397A1 Methods and means for producing efficient silencing construct using recombinational cloning |
| 08/01/2002 | CA2427676A1 Dna encoding human alpha and beta subunits of neuronal nicotinic acetylcholine receptor, cells transformed therewith, and recombinant cell line expressing a human alpha and beta subunits of neuronal nicotinic acetylcholine receptor |
| 08/01/2002 | CA2427647A1 Nucleic acid modification enzymes |
| 08/01/2002 | CA2427061A1 Methods and compositions for the identification and treatment of neurodegenerative disorders |
| 08/01/2002 | CA2426102A1 Method of diagnosing and treating cartilaginous disorders |
| 08/01/2002 | CA2425794A1 Nucleic acid molecules associated with plant cell proliferation and growth and uses thereof |
| 07/31/2002 | EP1227324A2 Har A polypeptides and nucleic acids and related methods and uses thereof |
| 07/31/2002 | EP1227323A1 Non-A, non-B hepatitis virus antigen, diagnostic methods and vaccines |
| 07/31/2002 | EP1227162A2 Sequences and methods for detection of Hepatitis B virus |
| 07/31/2002 | EP1227161A2 Primers, probes and methods for the detection of nucleic acids of hepatitis C viruses |
| 07/31/2002 | EP1227157A1 Swap/counter selection: a rapid cloning method |
| 07/31/2002 | EP1227156A2 A human protein kinase domain-containing protein |
| 07/31/2002 | EP1227155A1 Process for producing ubiquinone-10 |
| 07/31/2002 | EP1227154A2 Bacillus thuringiensis strains active against lepidopteran and coleopteran pests |
| 07/31/2002 | EP1227153A2 Serpin from Bifidobacteria |
| 07/31/2002 | EP1227152A1 Bacterial strain and genome of bifidobacterium |
| 07/31/2002 | EP1227151A1 Glucagon-like insulinotropic peptide analogs, compositions, and methods of use |
| 07/31/2002 | EP1227150A2 Androgen receptor complex-associated protein |
| 07/31/2002 | EP1227149A1 Novel protein and use thereof |
| 07/31/2002 | EP1227148A1 Gene ys68 concerning early hematopoiesis |
| 07/31/2002 | EP1227147A2 Recombinational cloning using engineered recombination sites |
| 07/31/2002 | EP1227146A1 A method for creating endothelial cell dysfunction in cell culture |
| 07/31/2002 | EP1227106A1 Pro-apoptotic proteins and DNA molecules encoding them |
| 07/31/2002 | EP1227105A1 Ghsr ligand polypeptides and dnas thereof |
| 07/31/2002 | EP1226871A2 Reactive probe chip and reactive detection sytem |
| 07/31/2002 | EP1226752A1 Transgenic non-human mammals for monitoring change in calcium ion concentration in cells |
| 07/31/2002 | EP1226441A1 Protein tyrosine kinase receptor polynucleotides, polypeptides, and antibodies |
| 07/31/2002 | EP1226436A2 Universal fluorescent sensors |
| 07/31/2002 | EP1226435A1 Axor35, a g-protein coupled receptor |